Various molecules found in the TME and expressed by tumor cells inhibit DC activation and drive DCs toward a suppressive, or regulatory phenotype including vascular endothelial growth factor (VEGF), PGE2, IL-10, and macrophage colony stimulating factor 1 (CSF-1) [97]. The gene discussed is VEGFA; the disease is neoplasm.